Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

Home Research Topics Science Science Issues Food Science

February 22, 2024

How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.

Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

Download

Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

Attachment Info

How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.
Modest expectations for the impact Ozempic and other similar drugs will have on obesity in America
65% of Americans say willpower alone is not enough for most people to lose weight and keep it off
Views on weight loss and willpower by respondents’ description of their own weight
Diet and exercise top public’s list of factors affecting a person’s weight; many also cite stress and anxiety
Women are more likely than men to say stress and anxiety affects a person’s weight a great deal

1615 L St. NW, Suite 800
Washington, DC 20036
USA
(+1) 202-419-4300 | Main
(+1) 202-857-8562 | Fax
(+1) 202-419-4372 | Media Inquiries

Research Topics

ABOUT PEW RESEARCH CENTER Pew Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping the world. It conducts public opinion polling, demographic research, media content analysis and other empirical social science research. Pew Research Center does not take policy positions. It is a subsidiary of The Pew Charitable Trusts.

About

Terms & Conditions

Cookie Settings

Reprints, Permissions & Use Policy

Feedback

Careers